Genome editing is transforming the way biological science is done and accelerating medical breakthroughs. CRISPR technology has reduced the barrier to creating predictable changes to DNA, encouraging scientific investigators and entrepreneurs to adopt and use the technology. However, robust and rigorous computational tools are critical for the correct analysis, interpretation and verification of biological results.
We build precision algorithms for analyzing genome editing experimental data, and provide customized computational support to address critical questions in the processing of next-generation sequencing data.
Please get in touch with us to get more information or to start a collaboration.
Company Details
- Employees
- 6
- Founded
- 2019
- Address
- Cambridge, Ma 02138, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://edilytics.com/
- Keywords
- NEWDELHI.
- HQ
- Cambridge, MA
Edilytics Questions
Edilytics's website is https://edilytics.com/
Edilytics's LinkedIn profile is https://www.linkedin.com/company/edilytics
Edilytics has
6 employees.
View email and phone details for 6
employees at Edilytics.
Edilytics's industry is
Biotechnology Research
Edilytics's top competitors are
Deep Venture Dao,
Crispr 2025 Meeting,
Echonous,
Merida Biosciences,
Resolution Therapeutics,
Genomicmd,
Castle Biosciences, Inc.,
Edelytics, Digital Marketing Agency,
Springtide Ventures,
Innosight.
Edilytics's categories are Biotechnology Research
Edilytics's founding year is 2019
